Understanding the Market | WuXi XDC surged over 8% during trading, announcing the signing of a strategic cooperation letter of intent with AbTis to accelerate the development of innovative ADC drugs
I'm PortAI, I can summarize articles.
WUXI XDC's stock price rose more than 8% during the trading session, with an increase of 8.13% as of the time of publication, reported at HKD 37.9, with a transaction volume of HKD 71.1095 million. The company announced the signing of a strategic cooperation letter of intent with the South Korean biotechnology company AbTis, and both parties will collaborate to promote the research and development of innovative ADC drugs, utilizing AbTis's advanced site-specific conjugation technology platform AbClick, aiming to improve the safety and efficacy of antibody-drug conjugates
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments